top of page
Create Your First Project
Start adding your projects to your portfolio. Click on "Manage Projects" to get started
REBYOTA: C. Difficile
C. difficile infection is potentially deadly. And difficult to diagnose. REBYOTA is the first FDA-approved treatment of its kind. This campaign urged sufferers to become their own advocates and speak up.
This ad gained +78MM impressions translating into 457K website visits, 516 opt-ins and 836 new social followers.
bottom of page